These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30139928)

  • 1. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Endocrinol; 2018 Nov; 239(2):241-252. PubMed ID: 30139928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Gastroenterol; 2017 Jan; 52(1):72-80. PubMed ID: 27075754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Eur J Pharmacol; 2019 Jun; 852():198-206. PubMed ID: 30935894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A balance theory of peripheral corticotropin-releasing factor receptor type 1 and type 2 signaling to induce colonic contractions and visceral hyperalgesia in rats.
    Nozu T; Takakusaki K; Okumura T
    Endocrinology; 2014 Dec; 155(12):4655-64. PubMed ID: 25279793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Neuropeptides; 2022 Aug; 94():102248. PubMed ID: 35526468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Neurogastroenterol Motil; 2020 Jun; 32(6):e13819. PubMed ID: 32056324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models.
    Nozu T; Arie H; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Int Immunopharmacol; 2024 May; 133():112099. PubMed ID: 38643709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats.
    Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
    J Gastroenterol Hepatol; 2019 Jan; 34(1):186-193. PubMed ID: 29966173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water avoidance stress induces visceral hyposensitivity through peripheral corticotropin releasing factor receptor type 2 and central dopamine D2 receptor in rats.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Neurogastroenterol Motil; 2016 Apr; 28(4):522-31. PubMed ID: 26662216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated water avoidance stress induces visceral hypersensitivity: Role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Gastroenterol Hepatol; 2017 Dec; 32(12):1958-1965. PubMed ID: 28299830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
    Nozu T; Okumura T
    J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Biomed Pharmacother; 2021 Jul; 139():111649. PubMed ID: 33957565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurotensin receptor 1 agonist PD149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Neurogastroenterol Motil; 2024 Dec; 36(12):e14925. PubMed ID: 39314062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRF1 receptors as a therapeutic target for irritable bowel syndrome.
    Martinez V; Taché Y
    Curr Pharm Des; 2006; 12(31):4071-88. PubMed ID: 17100612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Sci Rep; 2019 Dec; 9(1):19603. PubMed ID: 31862976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats.
    Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
    Eur J Pharmacol; 2018 Jan; 818():228-234. PubMed ID: 29107672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.
    Larauche M; Gourcerol G; Wang L; Pambukchian K; Brunnhuber S; Adelson DW; Rivier J; Million M; Taché Y
    Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G215-27. PubMed ID: 19407218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction.
    Vicario M; Alonso C; Guilarte M; Serra J; Martínez C; González-Castro AM; Lobo B; Antolín M; Andreu AL; García-Arumí E; Casellas M; Saperas E; Malagelada JR; Azpiroz F; Santos J
    Psychoneuroendocrinology; 2012 Jan; 37(1):65-77. PubMed ID: 21641728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.
    Taché Y; Martinez V; Million M; Maillot C
    Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.